PTC Therapeutics Inc (PTCT) Company Profile & Statistics

PTC Therapeutics Inc
PTCT
(Nasdaq - US)
Closed
42.92
+0.96 (+2.29%)
in:usd•As of: Nov 21, 2024 15:59 UTC -5
Open
42.22
High
43.38
Low
41.56

About PTC Therapeutics Inc

CEO

Mathew B. Klein

Headquarters

100 corporate court

south plainfield, nj 07080, united states

Auditor

Ernst & Young LLP

Employees

995

Share Holders

Website

www.ptcbio.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

PTC Therapeutics, Inc. is a biopharmaceutical company. It is focused on the discovery and development of orally administered, small-molecule drugs for genetic disorders, oncology and infectious disease. PTC Therapeutics, Inc. is based in South Plainfield, United States.

PTC Therapeutics Inc Statistics

Valuation Measures

Market Capitalization ²	3.31B
Enterprise Value	5.17B
Enterprise Value/EBITDA (ttm)	1.18K
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	N/A
Price to Sales (ttm)	3.37
Price to Cash (ytd)	16.25

Profitability

Gross Margin (ttm)	92.42%
Operating Margin (ttm)	-33.97%
Profit Margin (ttm)	-50.41%
Return on Equity (ttm)	N/A
Return on Invested Capital (ttm)	-41.71%
Return on Assets (ttm)	-16.44%

Income Statement

Revenue (ttm)	900.66M
Revenue Per Share (ttm)	11.68
Gross Profit (ttm)	830.43M
EBITDA (ttm)³	4.37M
Net Income Avi to Common (ttm)	-453.20M
Diluted EPS (ttm)	-5.94

Share Statistics

Beta (5Y Monthly)	0.63
52-Week Change	93.59%
S&P500 52-Week Change	30.55%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	77.13M
Dividend Yield	0.00%
Float ⁴	72.88M
% Held by Insiders	5.50%
% Held by Institutions	N/A

Balance Sheet

Total Cash (mrq)	1.01B
Total Cash Per Share (mrq)	13.14
Total Debt (mrq)	2.39B
Total Debt/Equity (mrq)	-226.24%
Current Ratio (mrq)	2.10%
Quick Ratio (mrq)	2.04%
Book Value Per Share (mrq)	-13.70

Cash Flow

Operating Cash Flow Per Share (ytd)	-1.01
Free Cash Flow (ytd)	-52.36M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

PTC Therapeutics Inc

Trade With A Regulated Broker